BRAF and melanoma: The vemurafenib‐resistant A375‐VR and M14‐VR melanoma cell lines were generated by chronic exposure of A375 and M14 cells, which harbour the BRAF V600E mutation and are susceptible to BRAFi,31 to increasing concentrations of vemurafenib.